A Comprehensive Review of Risk Factors for Venous Thromboembolism: From Epidemiology to Pathophysiology

Venous thromboembolism (VTE) is the third most common cause of death worldwide. The incidence of VTE varies according to different countries, ranging from 1-2 per 1000 person-years in Western Countries, while it is lower in Eastern Countries (70 per 1000 person-years) and lowest in breast, melanoma...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2023-02, Vol.24 (4), p.3169
Main Authors: Pastori, Daniele, Cormaci, Vito Maria, Marucci, Silvia, Franchino, Giovanni, Del Sole, Francesco, Capozza, Alessandro, Fallarino, Alessia, Corso, Chiara, Valeriani, Emanuele, Menichelli, Danilo, Pignatelli, Pasquale
Format: Article
Language:English
Subjects:
Anticoagulants
Antiphospholipid syndrome
Autoimmune diseases
Blood clots
Blood platelets
Breast cancer
Coagulation factors
Contraceptives
Coronaviruses
COVID-19
Diabetes mellitus
Endothelium
Epidemiology
Factor V
Female
Fractures
Genetic aspects
Health aspects
Hepatocytes
Humans
Immobilization
Lung cancer
Lung cancer, Non-small cell
Male
Melanoma
Molecular modelling
Mutation
Neutrophils
Oral contraceptives
Pathophysiology
Patients
Plasminogen activator inhibitors
Point mutation
Prostate cancer
Prothrombin
Pulmonary embolisms
Review
Risk Factors
SARS-CoV-2
Severe acute respiratory syndrome
Severe acute respiratory syndrome coronavirus 2
Thrombin
Thromboembolism
Thrombophilia - genetics
Thrombosis
Venous Thromboembolism - genetics
Venous Thrombosis - genetics
Women
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Venous thromboembolism (VTE) is the third most common cause of death worldwide. The incidence of VTE varies according to different countries, ranging from 1-2 per 1000 person-years in Western Countries, while it is lower in Eastern Countries (70 per 1000 person-years) and lowest in breast, melanoma and prostate cancer (
ISSN:1422-0067
1661-6596
1422-0067
DOI:10.3390/ijms24043169